«deCODE Genetics has built a world - class capability in the study of
the genetics of human disease,» said Robert A. Bradway, president and CEO at Amgen.
This will allow to understand more about genes we currently know very little about, and open up new avenues for research into
the genetics of human disease.
Not exact matches
This approach begins by using tools like advanced
human genetics to unravel the complexities
of disease and understand the fundamentals
of human biology.
The U.S. National Institutes
of Health (NIH) has made major investments in network approaches in many areas, including cancer biology, cardiovascular and metabolic
diseases, neurophysiology, and
human genetics and genomics.
Researchers also included a
human genetics study
of approximately 188,000 people, which found that carriers
of mutations that disable ANGPTL3 had nearly 40 percent fewer incidents
of coronary artery
disease as compared to those with fully functioning ANGPTL3.
One
of the primary goals
of genetics over the past decade has been to understand
human health and
disease in terms
of differences in DNA from person to person.
«While it seems that
genetics makes a substantial difference to the severity
of the heart
disease in our models, it does suggest that in
humans we may be able to better diagnose heart valve
disease in people with rheumatoid arthritis in the future.»
Adds Visscher: «This is entirely in line with theory and previous inference from SNP [variant] data, yet for some reason many researchers in
human genetics and epidemiology continue to believe that there is a lot
of non-additive genetic variation for common
diseases and quantitative traits.»
My clinical responsibilities now include part - time direction
of a hospital molecular
genetics lab that specializes in the diagnosis
of human genetic
diseases and hematologic malignancies — a return to my early research interest in
human genetics.
«In many cases we're still learning how these bacteria influence our risk
of disease, but understanding the
human genetics component is a necessary step in unraveling the mystery,» Knights said.
«One
of our killifish mutants recapitulates, but in a rapid manner, a
human disease called Dyskeratosis congenita, which is due to deficits in a complex involved in maintaining the end
of chromosomes, or telomeres,» says lead author Dr. Itamar Harel, a postdoctoral research fellow in
genetics.
«Through major
genetics studies,» Borenstein noted, «scientists have made valuable progress in gathering information on the species composition
of the
human microbiome in health and
disease.»
By studying how these genes cause defects in fly and mouse models, we can improve our insights into the mechanisms related to
human disease,» said corresponding author and Dr. Hugo J. Bellen, professor
of neuroscience and molecular and
human genetics at Baylor College
of Medicine and an investigator at the Howard Hughes Medical Institute.
His research interests include the molecular underpinnings
of cervical cancer (including developing genetic screens), the identification
of the genetic determinants
of quantitative traits in
humans, and the application
of massively parallel sequencing technology for understanding the
genetics of complex
disease.
This essentially gives us «barcodes»
of specific gene loci, which we can use to help untangle the complex
genetics of complex
diseases,» said Andrey Rzhetsky, PhD, professor
of genetic medicine and
human genetics at the University
of Chicago, who led the study.
Her research is both translational and clinical in nature and centers on the
human genetics of healthy skin aging and
diseases related to aging skin, including new treatments for advanced basal cell skin cancers.
While
genetics play a role in the development
of Lupus, a systemic autoimmune
disease that can attack any organ system in the
human body, so do environmental triggers, such as particulates in air pollution and ultraviolet light, explains Gaurav Gulati, MD, a physician - researcher at the University
of Cincinnati (UC) College
of Medicine.
The massive project, carried out by a private company in the country, deCODE
genetics, has yielded new
disease risk genes, insights into
human evolution, and a list
of more than 1000 genes that people can apparently live without.
Although genetically modified mice have been used widely to model neurodegenerative
diseases, they lack the typical neurodegeneration or overt neuronal loss seen in
human brains, says corresponding author Xiao - Jiang Li, MD, PhD, distinguished professor
of human genetics at Emory University School
of Medicine.
«We believe it is the first example illustrating the process
of a developing
human heart chamber in vitro,» said Kevin Healy, a UC Berkeley professor
of bioengineering, who is co-senior author
of the study with Dr. Bruce Conklin, a senior investigator at the Gladstone Institute
of Cardiovascular
Disease and a professor
of medical
genetics and cellular and molecular pharmacology at UC San Francisco.
Francis Collins, director
of the National
Human Genome Research Institute (NHGRI)-- which is funding this initiative jointly with the National Heart, Lung, and Blood Institute — says that having the genomes of three of the most important mammals in biomedical research in hand «will greatly speed the unraveling of the genetics and physiology» of human dis
Human Genome Research Institute (NHGRI)-- which is funding this initiative jointly with the National Heart, Lung, and Blood Institute — says that having the genomes
of three
of the most important mammals in biomedical research in hand «will greatly speed the unraveling
of the
genetics and physiology»
of human dis
human disease.
It's the study
of how information is added onto or influences the read - out
of genes and, Feinberg says, is not combined often enough with
genetics research to understand
human disease.
Some
of the genes may be important in understanding the
genetics behind
disease as well as the evolution
of the
human brain.
Thus far, the impact
of molecular
genetics on
human disease has been primarily to identify specifically which genes are implicated in specific
diseases.
For their seminal contributions to concepts and methods
of creating a genetic map in the
human, and
of positional cloning, leading to the identification
of thousands
of human disease genes and ushering in the era
of human genetics.
Once again we have used our capabilities in
human genetics to gain a new understanding
of the root causes
of a major
disease, that appear to act independently
of known environmental risk factors.
His research interests are largely focused upon elucidating the mechanisms
of mutagenesis underlying
human genetic
disease, but include genotype — phenotype relationships in various inherited conditions, as well as
human evolutionary and population
genetics.
«We can harness the power
of zebrafish
genetics to create genetic models
of human diseases.»
-- one
of the world's top researchers in the field
of human genetics, behavior and neuropsychiatric
diseases — has been named Endowed Chair in Behavioral Genomics by the Department
of Psychiatry and the University
of California, San Diego (UCSD) School
of Medicine.
About deCODE deCODE is a biopharmaceutical company applying its discoveries in
human genetics to the development
of diagnostics and drugs for common
diseases.
The findings open up an avenue for treating Huntington's as well as other inherited neurodegenerative
diseases, although more testing
of safety and long - term effects is needed, says senior author Xiao - Jiang Li, MD, PhD, distinguished professor
of human genetics at Emory University School
of Medicine.
Gholson J. Lyon Biochemistry, amino - terminal acetylation
of proteins,
human genetics, neuropsychiatric
diseases, whole genome sequencing
Dr. Lambert: In perhaps a generation, the field
of genetics will advance to a place where we will be able to perform real - time measurement
of changing biomarkers in the
human body, including genes expressed and the microbiome, and have early warning signals for
disease detection, prevention and intervention.
CSHL is a private, non-profit research and education institution dedicated to exploring molecular biology and
genetics in order to advance the understanding and ability to diagnose and treat cancers, neurological
diseases, and other causes
of human suffering.
Across the program, nearly 100 Helmsley - funded investigators are working to understand both how
human genetics and the gut microbiome can cause and exacerbate Crohn's
disease, and bring those insights into the development
of new treatments.
«This agreement is a part
of deCODE's ongoing strategy to unleash the value
of human genetics,» said Kari Stefansson, founder and CEO
of deCODE, «our research platform allows us to understand the genetic basis
of disease and modifiers
of clinical phenotypes in actual patient populations; by doing so, we can rapidly move from targets to patient stratification and from there to companion diagnostics.»
My goal is to contribute to the resolution
of this important problem by bringing to bear recent advances in
human genetics and integrative genomics and translating them in a mechanistic, systems - level understanding
of disease that is rooted in
human biology but also actionable from a drug development perspective.
«We believe it is the first example illustrating the process
of a developing
human heart chamber in vitro,» said Kevin Healy, PhD, a UC Berkeley professor
of bioengineering, who is co-senior author
of the study with Bruce Conklin, MD, a senior investigator at the Gladstone Institute
of Cardiovascular
Disease and a professor
of medical
genetics and cellular and molecular pharmacology at UC San Francisco.
But Dr. David Goldstein, director
of Duke University's Center for
Human Genome Variation, says, «Right now we know very, very little
of the
genetics of the
diseases that most people will get.»
The mission
of deCODE
genetics is to use
human genetics and genomics to acquire new knowledge about health and
disease, and work with pharmaceutical companies and healthcare providers to develop novel methods to identify, treat and prevent
diseases.
Using reverse genetic approaches, we are also working closely with the
human genetics community to create new strains
of mice carrying
human Mendelian
disease mutations.
The study
of human genetics has often focused on mutations that cause
disease.
PHENOMIN's involvement in the IMPC will fulfill a key item
of the the National Alliance for life sciences and health (AVIESAN) strategic plan that consists in applying mouse
genetics to analyze the mechanisms
of disease and to use this knowledge for advancing fundamental research and
human health (AVIESAN report on the use and needs
of mouse models in the French scientific community, 2010).
Further, his group pioneered expression quantitative trait locus (eQTL) studies, which enabled variation in global gene expression to be applied to
genetics of complex
human diseases.
Exploration
of these findings in the context
of human disease genetics provides insights into the role
of inherited variation in blood metabolic diversity and identify potential new opportunities for drug development and for understanding
disease.
The revolution in
human genetics has revealed a large number
of genes and pathways associated with these
diseases, and emerging methodologies are starting to systematically analyze the cellular and molecular circuitry underlying
disease.
«It comes as no surprise to me that the members
of ASHG have selected Dr. Nussbaum as their President - Elect,» said NHGRI Director Francis S. Collins, M.D., Ph.D. «Bob is a prominent leader in the field
of human genetics and has made considerable contributions to identifying the genetic abnormalities and destructive mechanisms involved in Parkinson's
disease and Lowe's Syndrome.
Centers for
Disease Control and Prevention (CDC) The Office
of Genomics and
Disease Prevention integrates advances in
human genetics into public health research, policies, and programs.
According to Ophir Klein, MD, PhD, the Charles J. Epstein Professor
of Human Genetics and chief
of the Division
of Medical
Genetics at UCSF, «We are looking forward to a close interaction between Dr. Rajkovic and our clinical
genetics faculty members in Pediatrics, Obstetrics, Internal Medicine and the Cancer Center, as well as with our colleagues working on genetic
diseases in other departments.
Helmsley - funded investigators are working to understand both how
human genetics and the gut microbiome can cause and exacerbate Crohn's
disease, so they can apply those insights into the development
of new treatments.